Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities researchers at JMP Securities in a research report issued on Thursday, Benzinga reports. They currently have a $32.00 price objective on the stock. JMP Securities’ price target suggests a potential upside of 40.41% from the company’s current price. A […]